Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. (2021)

First Author: Couillard S
Attributed to:  United Kingdom Refractory Asthma Stratification Programme (RASP-UK) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202104-1040le

PubMed Identifier: 34129808

Publication URI: http://europepmc.org/abstract/MED/34129808

Type: Journal Article/Review

Volume: 204

Parent Publication: American journal of respiratory and critical care medicine

Issue: 6

ISSN: 1073-449X